Washington Trust Advisors’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-43
Closed -$2.11K 746
2026
Q1
$2.11K Sell
43
-320
-88% -$14.9K ﹤0.01% 578
2025
Q4
$15.8K Hold
363
﹤0.01% 458
2025
Q3
$16.4K Buy
+363
New +$15.9K ﹤0.01% 466
2023
Q2
Sell
-597
Closed -$25K 698
2023
Q1
$25K Hold
597
﹤0.01% 389
2022
Q4
$25.8K Sell
597
-198
-25% -$7.82K ﹤0.01% 388
2022
Q3
$29K Sell
795
-3,087
-80% -$136K ﹤0.01% 463
2022
Q2
$176K Hold
3,882
0.02% 212
2022
Q1
$185K Sell
3,882
-1,669
-30% -$70.7K 0.01% 250
2021
Q4
$229K Buy
+5,551
New +$209K 0.02% 232

Other funds holding EXC

Washington Trust Advisors's EXC Position: Q2 2026 in Review

Washington Trust Advisors sold out of Exelon (EXC) in Q2 2026, closing a stake of 43 shares — an estimated $2.11K sold.

Washington Trust Advisors first reported a position in EXC in Q4 2021 and held it in 9 quarters. The position peaked at $229K in Q4 2021. 1,286 funds tracked by Wall St. Rank hold EXC as of Q2 2026.

  • Washington Trust Advisors reported no remaining Exelon position as of Q2 2026 after selling out during the quarter.
  • Washington Trust Advisors sold 43 Exelon shares in Q2 2026, an estimated $2.11K.
  • Washington Trust Advisors first reported a position in Exelon in Q4 2021 and held it in 9 quarters.
  • Washington Trust Advisors's Exelon position peaked at $229K in Q4 2021.
  • 1,286 funds tracked by Wall St. Rank held Exelon as of Q2 2026.

Based on Washington Trust Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.